Clinical Trial Update: SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares SBRT versus hypofractionated radiotherapy for biochemically recurrent or oligometastatic prostate cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biochemically Recurrent Prostate Cancer
• Oligometastatic Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Biochemically Recurrent Prostate Carcinoma, Oligometastatic Prostate Carcinoma | Phase 3 | Status: RECRUITING